Navigation Links
BD Ranked in the Top 100 Greenest Big Companies by Newsweek; Named Again to Dow Jones Sustainability World and North America Indexes
Date:10/7/2009

FRANKLIN LAKES, N.J., Oct. 7 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it is pleased to have been ranked in the top 100 companies in Newsweek's inaugural "Green Rankings" of the 500 largest U.S. corporations based on environmental performance, policies and reputation. BD placed third in the Healthcare sector and 83rd overall.

Additionally, BD has been selected as a component of the Dow Jones Sustainability World Index (DJSI World) and the DJSI North America Index for the fourth and fifth consecutive years, respectively. Dow Jones Sustainability Index assessments examine corporate economic, environmental and social performance, with a strong focus on long-term shareholder value. Inclusion in the DJSI World puts BD in the top 10 percent of companies in the healthcare sector assessed for sustainability leadership.

"BD strongly believes in balancing the triple bottom line -- achieving strong economic performance, promoting environmental stewardship and advancing social responsibility," said Edward J. Ludwig, BD Chairman and Chief Executive Officer. "We are making very good progress, and there is much more to be done."

Newsweek collaborated with TruCost (which calculated each companies Environmental Impact Score), KLD Research & Analytics (which created the Green Policies Score) and CorporateRegister.com, which conducted a reputation survey of CEOs, environmental officers and academics. To view the full list, please visit www.newsweek.com/green.

Launched in 1999, the Dow Jones Sustainability Indexes are the first global indexes tracking the financial performance of the leading sustainability-driven companies worldwide. To learn more, please visit www.sustainability-index.com.

About BD

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.

SOURCE BD


'/>"/>
SOURCE BD
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Companies Lead Fight Against Staph and Other Infectious Diseases
2. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
3. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
4. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
5. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
6. BIOCOMs 4th Annual DeviceFest Honors Companies
7. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
8. Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum
9. Facilitation Payments Seen as Problematic by Many Companies
10. Aspirin Named 8th World Wonder by Majority of Americans
11. American Board of Internal Medicine President Named to Alzheimers Study Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Februar 2017 ITL Limited, ( ASX: ... ist erfreut, für das zum 31. Dezember 2016 ... exzellente Ergebnisse vorlegen zu können. Eine vollständige Präsentation ... finden Sie hier . ... 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 ... gives comprehensive insights on the various drugs ... The report covers all the drugs that ... Preclinical & Clinical). The pipeline focuses on ... small molecules, antibodies, stem cell therapies, recombinant ...
(Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Urinary Incontinence ... What are the key drugs marketed for Urinary Incontinence ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a national ... social media management, corporate communications, SEO and cause marketing, is opening an office ... New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... host a diverse symposium on “Doping in Sport: How the Culture Might ... Richter & Hampton LLP. The symposium will be held at Pepperdine University in ...
(Date:2/23/2017)... ... 23, 2017 , ... Pink Pig Publishing LLC announces the ... explore the world from different perspectives. By providing a place for people of ... increase empathy, and find greater happiness. , "Our approach to structuring content ...
(Date:2/23/2017)... ... February 23, 2017 , ... Current Meditation , ... begin franchising throughout the U.S. starting this spring. Current Meditation focuses on “meditation ... meditation mainstream. Current Meditation will be the first meditation concept in the U.S. ...
(Date:2/23/2017)... Lincoln, RI (PRWEB) , ... February 23, 2017 ... ... announced today a new partnership with the Rhode Island Consortium for Autism Research ... provide an opportunity for children with autism spectrum disorder (ASD) to see films ...
Breaking Medicine News(10 mins):